Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review
Article in PharmacoEconomics (April 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in PharmacoEconomics (April 2024)
Article in HRB Open Research (April 2024)
Article in Cost Effectiveness and Resource Allocation (January 2024)